Yu Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yu Zhou has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Herrmann
DWI – Leibniz Institute for Interactive Materials, Aachen, Germany
5 shared publications - Robert Göstl
Department of Chemistry and Biology University of Wuppertal Wuppertal Germany
4 shared publications - Shuaidong Huo
Xiamen University
4 shared publications - Hua Lu
Peking University
3 shared publications Jingsong Yuan
Beijing National Laboratory for Molecular Sciences, Center for Soft Matter Science and Engineering, Key Laboratory of Polymer Chemistry and Physics of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China
3 shared publicationsYingqin Hou
Beijing National Laboratory for Molecular Sciences, Center for Soft Matter Science and Engineering, Key Laboratory of Polymer Chemistry and Physics of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China
3 shared publications
Latest Publications
- 15 May 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (23) , 7078-7104
Ultrasonic nanoreactors: porous nanomaterials as multimodal platforms for precision ultrasound-responsive therapy and sonotherapy in nanomedicine
This review highlights recent advances in porous nanomaterials as ultrasonic nanoreactors for ultrasound-responsive therapy and sonotherapy, covering their synthesis, mechanisms, and applications.
- 15 May 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (23) , 7078-7104
Ultrasonic nanoreactors: porous nanomaterials as multimodal platforms for precision ultrasound-responsive therapy and sonotherapy in nanomedicine
This review highlights recent advances in porous nanomaterials as ultrasonic nanoreactors for ultrasound-responsive therapy and sonotherapy, covering their synthesis, mechanisms, and applications.
- 13 December 2023
- Published by Elsevier in Chemical Engineering Journal
- Vol. 480
Supramolecular adhesive materials based on urea assembly
- 13 December 2023
- Published by Elsevier in Chemical Engineering Journal
- Vol. 480
Supramolecular adhesive materials based on urea assembly
- Open Access
- 11 March 2023
- Published by Wiley in Advanced Materials
- Vol. 35 (16) , e2210052
Fracture Detection in Bio‐Glues with Fluorescent‐Protein‐Based Optical Force Probes
Glues are being used to bond, seal, and repair in industry and biomedicine. The improvement of gluing performance is hence important for the development of new glues with better and balanced property spaces, which in turn necessitates a mechanistic understanding of their mechanical failure. Optical force probes (OFPs) allow the observation of mechanical material damage in polymers from the macro‐ down to the microscale, yet have never been employed in glues. Here, the development of a series of ratiometric OFPs based on fluorescent‐protein–dye and protein–protein conjugates and their incorporation into genetically engineered bio‐glues is reported. The OFPs are designed to efficiently modulate Förster resonance energy transfer upon force application thereby reporting on force‐induced molecular alterations independent of concentration and fluorescence intensity both spectrally and through their fluorescence lifetime. By fluorescence spectroscopy in solution and in the solid state and by fluorescence lifetime imaging microscopy, stress concentrations are visualized and adhesive and cohesive failure in the fracture zone is differentiated.
- 11 March 2023
- Published by Wiley in Advanced Materials
- Vol. 35 (16) , e2210052
Open AccessFracture Detection in Bio‐Glues with Fluorescent‐Protein‐Based Optical Force Probes
Glues are being used to bond, seal, and repair in industry and biomedicine. The improvement of gluing performance is hence important for the development of new glues with better and balanced property spaces, which in turn necessitates a mechanistic understanding of their mechanical failure. Optical force probes (OFPs) allow the observation of mechanical material damage in polymers from the macro‐ down to the microscale, yet have never been employed in glues. Here, the development of a series of ratiometric OFPs based on fluorescent‐protein–dye and protein–protein conjugates and their incorporation into genetically engineered bio‐glues is reported. The OFPs are designed to efficiently modulate Förster resonance energy transfer upon force application thereby reporting on force‐induced molecular alterations independent of concentration and fluorescence intensity both spectrally and through their fluorescence lifetime. By fluorescence spectroscopy in solution and in the solid state and by fluorescence lifetime imaging microscopy, stress concentrations are visualized and adhesive and cohesive failure in the fracture zone is differentiated.
- 7 July 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (60) , 7438-7440
Reversible regulation of metallo-base-pair interactions for DNA dehybridization by ultrasound
Ultrasound leads to the reversible dissociation of DNA metallo-base-pairs when these motifs are functionalized with oligodeoxynucleotide sequences of sufficient length.
- 7 July 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (60) , 7438-7440
Reversible regulation of metallo-base-pair interactions for DNA dehybridization by ultrasound
Ultrasound leads to the reversible dissociation of DNA metallo-base-pairs when these motifs are functionalized with oligodeoxynucleotide sequences of sufficient length.
- Open Access
- 26 October 2020
- Published by Wiley in Angewandte Chemie
- Vol. 133 (3) , 1515-1519
Kontrolle über die optische und katalytische Aktivität gentechnisch hergestellter Proteine mit Ultraschall
Ultraschall (US) erzeugt mittels Kavitation mechanische Kräfte, die Polymerketten in Lösung dehnen und brechen. Diese Art der Polymer‐Mechanochemie wird für synthetische Polymere, nicht aber für Biomakromoleküle verwendet, obwohl US biokompatibel ist und gemeinhin für die medizinische Therapie sowie für die Bildgebung in vivo eingesetzt wird. Die Möglichkeit, die Aktivität von Proteinen durch US zu kontrollieren, wäre daher ein wichtiger Meilenstein für diese Disziplinen. Hier zeigen wir die ersten Beispiele für die selektive Aktivierung und Deaktivierung von Proteinen durch US. Mit der Verwendung von GFP als Modellsystem zeigen wir modellhaft, wie Proteine mit US‐Empfindlichkeit ausgestattet werden können. Der Einbau von langen und hochgeladenen Domänen ermöglicht eine effiziente Kraftübertragung auf die Proteinstruktur. Dieses Prinzip nutzen wir dann, um die katalytische Aktivität von Trypsin zu aktivieren, indem wir die Freisetzung seines Inhibitors auslösen. Wir erwarten, dass das Konzept des Ein‐ und Ausschaltens der Proteinaktivität durch US als Bauplan für die Fernsteuerung anderer bioaktiver Moleküle dienen wird.
- 26 October 2020
- Published by Wiley in Angewandte Chemie
- Vol. 133 (3) , 1515-1519
Open AccessKontrolle über die optische und katalytische Aktivität gentechnisch hergestellter Proteine mit Ultraschall
Ultraschall (US) erzeugt mittels Kavitation mechanische Kräfte, die Polymerketten in Lösung dehnen und brechen. Diese Art der Polymer‐Mechanochemie wird für synthetische Polymere, nicht aber für Biomakromoleküle verwendet, obwohl US biokompatibel ist und gemeinhin für die medizinische Therapie sowie für die Bildgebung in vivo eingesetzt wird. Die Möglichkeit, die Aktivität von Proteinen durch US zu kontrollieren, wäre daher ein wichtiger Meilenstein für diese Disziplinen. Hier zeigen wir die ersten Beispiele für die selektive Aktivierung und Deaktivierung von Proteinen durch US. Mit der Verwendung von GFP als Modellsystem zeigen wir modellhaft, wie Proteine mit US‐Empfindlichkeit ausgestattet werden können. Der Einbau von langen und hochgeladenen Domänen ermöglicht eine effiziente Kraftübertragung auf die Proteinstruktur. Dieses Prinzip nutzen wir dann, um die katalytische Aktivität von Trypsin zu aktivieren, indem wir die Freisetzung seines Inhibitors auslösen. Wir erwarten, dass das Konzept des Ein‐ und Ausschaltens der Proteinaktivität durch US als Bauplan für die Fernsteuerung anderer bioaktiver Moleküle dienen wird.
- Open Access
- 26 October 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (3) , 1493-1497
Controlling Optical and Catalytic Activity of Genetically Engineered Proteins by Ultrasound
Ultrasound (US) produces cavitation‐induced mechanical forces stretching and breaking polymer chains in solution. This type of polymer mechanochemistry is widely used for synthetic polymers, but not biomacromolecules, even though US is biocompatible and commonly used for medical therapy as well as in vivo imaging. The ability to control protein activity by US would thus be a major stepping‐stone for these disciplines. Here, we provide the first examples of selective protein activation and deactivation by means of US. Using GFP as a model system, we engineer US sensitivity into proteins by design. The incorporation of long and highly charged domains enables the efficient transfer of force to the protein structure. We then use this principle to activate the catalytic activity of trypsin by inducing the release of its inhibitor. We expect that this concept to switch “on” and “off” protein activity by US will serve as a blueprint to remotely control other bioactive molecules.
- 26 October 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (3) , 1493-1497
Open AccessControlling Optical and Catalytic Activity of Genetically Engineered Proteins by Ultrasound
Ultrasound (US) produces cavitation‐induced mechanical forces stretching and breaking polymer chains in solution. This type of polymer mechanochemistry is widely used for synthetic polymers, but not biomacromolecules, even though US is biocompatible and commonly used for medical therapy as well as in vivo imaging. The ability to control protein activity by US would thus be a major stepping‐stone for these disciplines. Here, we provide the first examples of selective protein activation and deactivation by means of US. Using GFP as a model system, we engineer US sensitivity into proteins by design. The incorporation of long and highly charged domains enables the efficient transfer of force to the protein structure. We then use this principle to activate the catalytic activity of trypsin by inducing the release of its inhibitor. We expect that this concept to switch “on” and “off” protein activity by US will serve as a blueprint to remotely control other bioactive molecules.
- Open Access
- 17 July 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (29) , eabc0810
De novo rational design of a freestanding, supercharged polypeptide, proton-conducting membrane
Innovative bio-inspired device based on supercharged spider silk nanostructures engineered to efficiently transport protons.
- 17 July 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (29) , eabc0810
Open AccessDe novo rational design of a freestanding, supercharged polypeptide, proton-conducting membrane
Innovative bio-inspired device based on supercharged spider silk nanostructures engineered to efficiently transport protons.
- Open Access
- 8 January 2019
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 5 (2) , 229-236
Therapeutic Protein PEPylation: The Helix of Nonfouling Synthetic Polypeptides Minimizes Antidrug Antibody Generation
Polymer conjugation is a clinically proven approach to generate long acting protein drugs with decreased immune responses. Although poly(ethylene glycol) (PEG) is one of the most commonly used conjugation partners due to its unstructured conformation, its therapeutic application is limited by its poor biodegradability, propensity to induce an anti-PEG immune response, and the resultant accelerated blood clearance (ABC) effect. Moreover, the prevailing preference of unstructured polymers for protein conjugation still lacks strong animal data support with appropriate control reagents. By using two biodegradable synthetic polypeptides with similar structural compositions (l-P(EG3Glu) and dl-P(EG3Glu)) for site-specific protein modification, in the current study, we systematically investigate the effect of the polymer conformation on the in vivo pharmacological performances of the resulting conjugates. Our results reveal that the conjugate l20K-IFN, interferon (IFN) modified with the helical polypeptide l-P(EG3Glu) shows improved binding affinity, in vitro antiproliferative activity, and in vivo efficacy compared to those modified with the unstructured polypeptide analogue dl-P(EG3Glu) or PEG. Moreover, l20K-IFN triggered significantly less antidrug and antipolymer antibodies than the other two. Importantly, the unusual findings observed in the IFN series are reproduced in a human growth hormone (GH) conjugate series. Subcutaneously infused l20K-GH, GH modified with l-P(EG3Glu), evokes considerably less anti-GH and antipolymer antibodies compared to those modified with dl-P(EG3Glu) or PEG (dl20K-GH or PEG20K-GH). As a result, repeated injections of dl20K-GH or PEG20K-GH, but not l20K-GH, result in a clear ABC effect and significantly diminished drug availability in the blood. Meanwhile, immature mouse bone marrow cells incubated with the helical l20K-GH exhibit decreased drug uptake and secretion of proinflammatory cytokines compared to those treated with one of the other two GH conjugates bearing unstructured polymers. Taken together, the current study highlights an urgent necessity to systematically reassess the pros and cons of choosing unstructured polymers for protein conjugation. Furthermore, our results also lay the foundation for the development of next-generation biohybrid drugs based on helical synthetic polypeptides.
- 8 January 2019
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 5 (2) , 229-236
Open AccessTherapeutic Protein PEPylation: The Helix of Nonfouling Synthetic Polypeptides Minimizes Antidrug Antibody Generation
Polymer conjugation is a clinically proven approach to generate long acting protein drugs with decreased immune responses. Although poly(ethylene glycol) (PEG) is one of the most commonly used conjugation partners due to its unstructured conformation, its therapeutic application is limited by its poor biodegradability, propensity to induce an anti-PEG immune response, and the resultant accelerated blood clearance (ABC) effect. Moreover, the prevailing preference of unstructured polymers for protein conjugation still lacks strong animal data support with appropriate control reagents. By using two biodegradable synthetic polypeptides with similar structural compositions (l-P(EG3Glu) and dl-P(EG3Glu)) for site-specific protein modification, in the current study, we systematically investigate the effect of the polymer conformation on the in vivo pharmacological performances of the resulting conjugates. Our results reveal that the conjugate l20K-IFN, interferon (IFN) modified with the helical polypeptide l-P(EG3Glu) shows improved binding affinity, in vitro antiproliferative activity, and in vivo efficacy compared to those modified with the unstructured polypeptide analogue dl-P(EG3Glu) or PEG. Moreover, l20K-IFN triggered significantly less antidrug and antipolymer antibodies than the other two. Importantly, the unusual findings observed in the IFN series are reproduced in a human growth hormone (GH) conjugate series. Subcutaneously infused l20K-GH, GH modified with l-P(EG3Glu), evokes considerably less anti-GH and antipolymer antibodies compared to those modified with dl-P(EG3Glu) or PEG (dl20K-GH or PEG20K-GH). As a result, repeated injections of dl20K-GH or PEG20K-GH, but not l20K-GH, result in a clear ABC effect and significantly diminished drug availability in the blood. Meanwhile, immature mouse bone marrow cells incubated with the helical l20K-GH exhibit decreased drug uptake and secretion of proinflammatory cytokines compared to those treated with one of the other two GH conjugates bearing unstructured polymers. Taken together, the current study highlights an urgent necessity to systematically reassess the pros and cons of choosing unstructured polymers for protein conjugation. Furthermore, our results also lay the foundation for the development of next-generation biohybrid drugs based on helical synthetic polypeptides.
- 11 January 2018
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 140 (3) , 1170-1178
Macrocyclization of Interferon–Poly(α-amino acid) Conjugates Significantly Improves the Tumor Retention, Penetration, and Antitumor Efficacy
Cyclization and polymer conjugation are two commonly used approaches for enhancing the pharmacological properties of protein drugs. However, cyclization of parental proteins often only affords a modest improvement in biochemical or cell-based in vitro assays. Moreover, very few studies have included a systematic pharmacological evaluation of cyclized protein-based therapeutics in live animals. On the other hand, polymer-conjugated proteins have longer circulation half-lives but usually show poor tumor penetration and suboptimal pharmacodynamics due to increased steric hindrance. We herein report the generation of a head-to-tail interferon–poly(α-amino acid) macrocycle conjugate circ-P(EG3Glu)20-IFN by combining the aforementioned two approaches. We then compared the antitumor pharmacological activity of this macrocycle conjugate against its linear counterparts, N-P(EG3Glu)20-IFN, C-IFN-P(EG3Glu)20, and C-IFN-PEG. Our results found circ-P(EG3Glu)20-IFN to show considerably greater stability, binding affinity, and in vitro antiproliferative activity toward OVCAR3 cells than the three linear conjugates. More importantly, circ-P(EG3Glu)20-IFN exhibited longer circulation half-life, remarkably higher tumor retention, and deeper tumor penetration in vivo. As a result, administration of the macrocyclic conjugate could effectively inhibit tumor progression and extend survival in mice bearing established xenograft human OVCAR3 or SKOV3 tumors without causing severe paraneoplastic syndromes. Taken together, our study provided until now the most relevant experimental evidence in strong support of the in vivo benefit of macrocyclization of protein–polymer conjugates and for its application in next-generation therapeutics.
- 11 January 2018
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 140 (3) , 1170-1178
Macrocyclization of Interferon–Poly(α-amino acid) Conjugates Significantly Improves the Tumor Retention, Penetration, and Antitumor Efficacy
Cyclization and polymer conjugation are two commonly used approaches for enhancing the pharmacological properties of protein drugs. However, cyclization of parental proteins often only affords a modest improvement in biochemical or cell-based in vitro assays. Moreover, very few studies have included a systematic pharmacological evaluation of cyclized protein-based therapeutics in live animals. On the other hand, polymer-conjugated proteins have longer circulation half-lives but usually show poor tumor penetration and suboptimal pharmacodynamics due to increased steric hindrance. We herein report the generation of a head-to-tail interferon–poly(α-amino acid) macrocycle conjugate circ-P(EG3Glu)20-IFN by combining the aforementioned two approaches. We then compared the antitumor pharmacological activity of this macrocycle conjugate against its linear counterparts, N-P(EG3Glu)20-IFN, C-IFN-P(EG3Glu)20, and C-IFN-PEG. Our results found circ-P(EG3Glu)20-IFN to show considerably greater stability, binding affinity, and in vitro antiproliferative activity toward OVCAR3 cells than the three linear conjugates. More importantly, circ-P(EG3Glu)20-IFN exhibited longer circulation half-life, remarkably higher tumor retention, and deeper tumor penetration in vivo. As a result, administration of the macrocyclic conjugate could effectively inhibit tumor progression and extend survival in mice bearing established xenograft human OVCAR3 or SKOV3 tumors without causing severe paraneoplastic syndromes. Taken together, our study provided until now the most relevant experimental evidence in strong support of the in vivo benefit of macrocyclization of protein–polymer conjugates and for its application in next-generation therapeutics.